Fig. 5From: Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatmentChanges in CD4+ T cell counts in patients (n = 8/54) who experienced at least one decrease in the CD4+ cell count to below 300/mm3 during follow upBack to article page